Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). Additionally we are shipping ALP Kits (42) and ALP Proteins (14) and many more products for this protein.
Showing 10 out of 428 products:
Human Monoclonal ALP Primary Antibody for ICC, FACS - ABIN258034
Leitner, Szlauer, Ellinger, Ellinger, Zimmer, Fuchs: Placental alkaline phosphatase expression at the apical and basal plasma membrane in term villous trophoblasts. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2001
Show all 9 Pubmed References
Human Monoclonal ALP Primary Antibody for IHC, ELISA - ABIN965542
Llinas, Stura, Ménez, Kiss, Stigbrand, Millán, Le Du: Structural studies of human placental alkaline phosphatase in complex with functional ligands. in Journal of molecular biology 2005
Show all 2 Pubmed References
Human Monoclonal ALP Primary Antibody for ELISA, IHC (f) - ABIN94454
Millán, Stigbrand: Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. in European journal of biochemistry / FEBS 1983
Show all 2 Pubmed References
Human Monoclonal ALP Primary Antibody for IHC, ELISA - ABIN968956
Chen, Anderson, Hiroi, Medof: Proprotein interaction with the GPI transamidase. in Journal of cellular biochemistry 2003
Cow (Bovine) Polyclonal ALP Primary Antibody for IHC, WB - ABIN2777088
Lazrek, Goffard, Schanen, Karquel, Bocket, Lion, Devaux, Hedouin, Gosset, Hober: Detection of hepatitis C virus antibodies and RNA among medicolegal autopsy cases in Northern France. in Diagnostic microbiology and infectious disease 2006
Show all 2 Pubmed References
Human Monoclonal ALP Primary Antibody for ELISA, ID - ABIN5572442
Han, Yang, Li, Li, Zheng, Yu, Zhang, Zheng, Yi, Li, Guo, Zhou: RhoB/ROCK mediates oxygen-glucose deprivation-stimulated syncytiotrophoblast microparticle shedding in preeclampsia. in Cell and tissue research 2016
A panel including p53 (show TP53 Antibodies) and ASRGL1 (show ASRGL1 Antibodies) immunohistochemistry was identified as the most accurate predictor of relapse-free and disease-specific survival. Within this panel, patients were allocated into high- (5.9%), intermediate- (29.5%) and low- (64.6%) risk groups where high-risk patients had a 30-fold risk (P<0.001) of dying of EEC compared to the low-risk group.
In a prospective setting ASRGL1 (show ASRGL1 Antibodies) validates as a strong prognostic biomarker in endometrial carcinoma. Loss of ASRGL1 (show ASRGL1 Antibodies) is associated with aggressive disease and poor survival.
Our studies suggest that the p.G178R mutation in ASRGL1 (show ASRGL1 Antibodies) leads to photoreceptor degeneration resulting in progressive vision loss.
Concentrations of PLAP were elevated in gingival crevicular fluid of patients with pre-eclampsia.
SALL4 (show SALL4 Antibodies) also outperformed PLAP on a small sample of cytology blocks. Although SALL4 (show SALL4 Antibodies) is not entirely specific, it is a highly sensitive marker with strong diffuse nuclear reactivity in the majority of MGCTs in the posttreatment setting, at significantly higher levels than PLAP
Multiple negatively charged small molecules interact within the active site of ASRGL1 (show ASRGL1 Antibodies) to act as a base in promoting cleavage.
Reduced expression of ASRGL1 (show ASRGL1 Antibodies), defined as <75% positively stained tumor cells, was significantly associated with poor prognosis and reduced disease-specific survival in endometrioid endometrial adenocarcinoma (EEA).
Quantum-mechanical computational methods were employed to study the catalytic mechanism of human placental AP (PLAP). An active-site model was used, constructed on the basis of the X-ray crystal structure of the enzyme.
term placental explants, but not their conditioned medium, can de-phosphorylate IGFBP-1 (show IGFBPI Antibodies) through the action of placental alkaline phosphatase
Anti-PLAP antibodies may serve as a modular building blocks for the development of targeted therapeutic products, armed with cytotoxic drugs, radionuclides or cytokines as payloads.
There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2 while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme, also referred to as the heat stable form, that is expressed primarily in the placenta although it is closely related to the intestinal form of the enzyme as well as to the placental-like form. The coding sequence for this form of alkaline phosphatase is unique in that the 3' untranslated region contains multiple copies of an Alu family repeat. In addition, this gene is polymorphic and three common alleles (type 1, type 2 and type 3) for this form of alkaline phosphatase have been well characterized.
, L-asparagine amidohydrolase
, asparaginase-like 1 protein
, asparaginase-like protein 1
, isoaspartyl dipeptidase
, isoaspartyl peptidase/L-asparaginase
, Regan isozyme
, alkaline phosphatase Regan isozyme
, alkaline phosphatase, placental type
, alkaline phosphomonoesterase
, placental alkaline phosphatase 1
, bacterial alkaline phosphatase
, alkaline phosphatase, placental (Regan isozyme)
, C-C motif chemokine 27
, tissue-nonspecific alkaline phosphatase
, alkaline phosphatase
, alkaline phosphatase, intestinal
, PDZ and LIM domain protein 3
, actinin alpha 2 associated LIM protein
, actinin-associated LIM protein
, alpha-actinin-2-associated LIM protein